SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001493152-24-014529
Filing Date
2024-04-15
Accepted
2024-04-15 06:31:50
Documents
103

Document Format Files

Seq Description Document Type Size
1 forms-1a.htm   iXBRL S-1/A 4311840
2 ex4-6.htm EX-4.6 140848
3 ex4-7.htm EX-4.7 146659
4 ex4-10.htm EX-4.10 144365
5 ex4-11.htm EX-4.11 138869
6 ex4-12.htm EX-4.12 138903
7 ex10-38.htm EX-10.38 300494
8 ex10-49.htm EX-10.49 18344
9 ex10-50.htm EX-10.50 144711
10 ex10-51.htm EX-10.51 19700
11 ex23-1.htm EX-23.1 4328
12 forms-1_001.jpg GRAPHIC 4937
13 forms-1a_001.jpg GRAPHIC 69735
14 forms-1a_002.jpg GRAPHIC 69570
  Complete submission text file 0001493152-24-014529.txt   17221346

Data Files

Seq Description Document Type Size
15 XBRL SCHEMA FILE cldi-20231231.xsd EX-101.SCH 112134
16 XBRL CALCULATION FILE cldi-20231231_cal.xml EX-101.CAL 99394
17 XBRL DEFINITION FILE cldi-20231231_def.xml EX-101.DEF 558812
18 XBRL LABEL FILE cldi-20231231_lab.xml EX-101.LAB 800251
19 XBRL PRESENTATION FILE cldi-20231231_pre.xml EX-101.PRE 630127
106 EXTRACTED XBRL INSTANCE DOCUMENT forms-1a_htm.xml XML 2248708
Mailing Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121 858-794-9600
Calidi Biotherapeutics, Inc. (Filer) CIK: 0001855485 (see all company filings)

IRS No.: 862967193 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-276741 | Film No.: 24843064
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)